Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Jul 6;12(7):e0180444.
doi: 10.1371/journal.pone.0180444. eCollection 2017.

Validation of the mSOAR and SOAR scores to predict early mortality in Chinese acute stroke patients

Hui Wang  1   2   3   4   5 , Yuesong Pan  1   2   3   4   6 , Xia Meng  1   2   3   4 , Chunjuan Wang  1   2   3   4 , Xiaoling Liao  1   2   3   4 , David Wang  7 , Xingquan Zhao  1   2   3   4 , Liping Liu  1   2   3   4 , Hao Li  1   2   3   4 , Yilong Wang  1   2   3   4 , Yongjun Wang  1   2   3   4   5
Affiliations
Multicenter Study

Validation of the mSOAR and SOAR scores to predict early mortality in Chinese acute stroke patients

Hui Wang et al. PLoS One. .

Abstract

Background: It is unclear in Chinese patients with acute stroke how the SOAR (stroke subtype, Oxfordshire Community Stroke Project classification, age, and prestrike modified Rankin) and mSOAR (modified-SOAR) scores performed in predicting discharge mortality and 3-month mortality. We aimed to validate the predictability of these scores in this cohort.

Methods: Data from the China National Stroke Registry (CNSR) study was used to perform the mSOAR and SOAR scores for predicting the discharge and 3-month mortality in acute stroke patients.

Results: A total of 11073 acute stroke patients were included in present study. The increased mSOAR and SOAR scores were closely related to higher death risk in acute stroke patients. For discharge mortality, the area under the receiver-operator curve (AUC) of the mSOAR and SOAR scores were 0.784 (95% CI 0.761-0.807) and 0.722 (95% CI: 0.698-0.746). For 3-month mortality, they were 0.787 (95% CI: 0.771-0.803) and 0.704 (95% CI: 0.687-0.721), respectively. The mSOAR and SOAR scores showed significant correlation between the predicted and observed probabilities of discharge mortality (mSOAR: r = 0.945, P = 0.001; SOAR: r = 0.994, P<0.001) and 3-month mortality (mSOAR: r = 0.984, P<0.001; SOAR: r = 0.999; P<0.001).

Conclusions: The mSOAR score predicted reliably the risk of death in Chinese acute stroke patients.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1
The discharge mortality and 3-month mortality were prognosticated by SOAR score (A) and mSOAR score (B). Patients with mSOAR score of 7 and 8 were merged into score of 6 for small sample size. Patients with SOAR score of 5 and 6 were merged into score of 4 for small sample size.
Fig 2
Fig 2. Receiver operating characteristic (ROC) curve analysis comparing mSOAR and SOAR score with other scores.
The area under the receiver-operator curve (AUC) for prediction of discharges mortality (A) and 3-months mortality (B).
Fig 3
Fig 3
Calibration plot of (A) SOAR score for discharge mortality, (B) mSOAR score for discharge mortality, (C) SOAR score for 3-month mortality, and (D) mSOAR score for 3-month mortality. The vertical lines indicate the 95% confidence intervals of observed rates of mortality.
See this image and copyright information in PMC

References

    1. Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245–54. ; PubMed Central PMCID: PMC4181600. - PMC - PubMed
    1. Krishnamurthi RV, Feigin VL, Forouzanfar MH, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. The Lancet Global health. 2013;1(5):e259–81. doi: 10.1016/S2214-109X(13)70089-5 ; PubMed Central PMCID: PMC4181351. - DOI - PMC - PubMed
    1. Kim BJ, Han MK, Park TH, Park SS, Lee KB, Lee BC, et al. Low-Versus Standard-Dose Alteplase for Ischemic Strokes Within 4.5 Hours: A Comparative Effectiveness and Safety Study. Stroke; a journal of cerebral circulation. 2015;46(9):2541–8. doi: 10.1161/STROKEAHA.115.010180 . - DOI - PubMed
    1. Machado C, Pinho J, Alves JN, Santos AF, Ferreira Mdo C, Abreu MJ, et al. Five-Year Outcome in Stroke Patients Submitted to Thrombolysis. Stroke; a journal of cerebral circulation. 2015;46(8):2312–4. doi: 10.1161/STROKEAHA.115.009842 . - DOI - PubMed
    1. Gensicke H, Strbian D, Zinkstok SM, Scheitz JF, Bill O, Hametner C, et al. Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke. Stroke; a journal of cerebral circulation. 2016;47(2):450–6. doi: 10.1161/STROKEAHA.115.011674 . - DOI - PubMed